Paratek Pharmaceuticals, Inc.
PRTK
PRTK was delisted on the 20th of September, 2023.
62 hedge funds and large institutions have $213M invested in Paratek Pharmaceuticals, Inc. in 2016 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 18 increasing their positions, 15 reducing their positions, and 6 closing their positions.
20% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 15
0% more funds holding
Funds holding: 62 → 62 (0)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 6
18% less capital invested
Capital invested by funds: $259M → $213M (-$45.8M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FIG
Fortress Investment Group
New York
|
+$6.63M |
| 2 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$2.94M |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
+$1.07M |
| 4 |
TC
TFS Capital
West Chester,
Pennsylvania
|
+$687K |
| 5 |
LPL Financial
San Diego,
California
|
+$398K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OA
Omega Advisors
New York
|
-$2.25M |
| 2 |
TI
Turner Investments
Berwyn,
Pennsylvania
|
-$1.17M |
| 3 |
LOAMU
Lombard Odier Asset Management (USA)
New York
|
-$793K |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$765K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$441K |
PRTK Hedge Fund Activity: Q1 2016 in Review
62 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Paratek Pharmaceuticals, Inc. (PRTK) for Q1 2016, worth a combined $213M — down 18% from $259M a quarter earlier.
Fund positioning in PRTK was balanced in Q1 2016: 6 funds opened new positions, 6 closed out, 18 added to existing stakes and 15 trimmed.
The largest buyer was Fortress Investment Group, opening a new position worth an estimated $6.63M. The largest seller was Omega Advisors, exiting entirely with an estimated $2.25M sold.
- 62 institutional investors held Paratek Pharmaceuticals, Inc. (PRTK) as of Q1 2016, unchanged from Q4 2015.
- Funds reported $213M of Paratek Pharmaceuticals, Inc. stock for Q1 2016, down 18% quarter-over-quarter.
- 6 funds opened new Paratek Pharmaceuticals, Inc. positions in Q1 2016 and 6 closed out, a net change of 0 holders.
- The largest Paratek Pharmaceuticals, Inc. buyer in Q1 2016 was Fortress Investment Group, an estimated $6.63M added.
- The largest Paratek Pharmaceuticals, Inc. seller in Q1 2016 was Omega Advisors, an estimated $2.25M sold.
Based on aggregated 13F filings for Q1 2016.